These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia. Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209 [TBL] [Abstract][Full Text] [Related]
3. Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage. Montefiori LE; Mullighan CG Best Pract Res Clin Haematol; 2021 Dec; 34(4):101329. PubMed ID: 34865701 [TBL] [Abstract][Full Text] [Related]
4. A far downstream enhancer for murine Bcl11b controls its T-cell specific expression. Li L; Zhang JA; Dose M; Kueh HY; Mosadeghi R; Gounari F; Rothenberg EV Blood; 2013 Aug; 122(6):902-11. PubMed ID: 23741008 [TBL] [Abstract][Full Text] [Related]
5. Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations. Abbas S; Sanders MA; Zeilemaker A; Geertsma-Kleinekoort WM; Koenders JE; Kavelaars FG; Abbas ZG; Mahamoud S; Chu IW; Hoogenboezem R; Peeters JK; van Drunen E; van Galen J; Beverloo HB; Löwenberg B; Valk PJ Haematologica; 2014 May; 99(5):848-57. PubMed ID: 24441149 [TBL] [Abstract][Full Text] [Related]
6. Structural variation cooperates with permissive chromatin to control enhancer hijacking-mediated oncogenic transcription. Botten GA; Zhang Y; Dudnyk K; Kim YJ; Liu X; Sanders JT; Imanci A; Droin N; Cao H; Kaphle P; Dickerson KE; Kumar KR; Chen M; Chen W; Solary E; Ly P; Zhou J; Xu J Blood; 2023 Jul; 142(4):336-351. PubMed ID: 36947815 [TBL] [Abstract][Full Text] [Related]
7. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1. Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084 [TBL] [Abstract][Full Text] [Related]
13. Epigenetic Dynamics in the Function of T-Lineage Regulatory Factor Bcl11b. Sidwell T; Rothenberg EV Front Immunol; 2021; 12():669498. PubMed ID: 33936112 [TBL] [Abstract][Full Text] [Related]
14. BCL11B suppression does not influence CD34(+) cell differentiation and proliferation. Shen Q; Huang X; Chen S; Yang L; Chen S; Li B; Wu X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y Hematology; 2012 Nov; 17(6):329-33. PubMed ID: 23168072 [TBL] [Abstract][Full Text] [Related]
15. Role of the transcription factor Bcl11b in development and lymphomagenesis. Kominami R Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(3):72-87. PubMed ID: 22450536 [TBL] [Abstract][Full Text] [Related]
16. The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation. Ha VL; Luong A; Li F; Casero D; Malvar J; Kim YM; Bhatia R; Crooks GM; Parekh C Leukemia; 2017 Nov; 31(11):2503-2514. PubMed ID: 28232744 [TBL] [Abstract][Full Text] [Related]
17. Non-coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate. Isoda T; Moore AJ; He Z; Chandra V; Aida M; Denholtz M; Piet van Hamburg J; Fisch KM; Chang AN; Fahl SP; Wiest DL; Murre C Cell; 2017 Sep; 171(1):103-119.e18. PubMed ID: 28938112 [TBL] [Abstract][Full Text] [Related]
19. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Li L; Leid M; Rothenberg EV Science; 2010 Jul; 329(5987):89-93. PubMed ID: 20595614 [TBL] [Abstract][Full Text] [Related]